EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function

Anna Maria Bednarek iD, Aleksander Jerzy Owczarek iD, Dominika Dziadosz iD, Magdalena Olszanecka-Glinianowicz iD, Jerzy Tadeusz Chudek iD

Diagnostics · 06.03.2026 · 16 (5) · 786

DOI: 10.3390/diagnostics16050786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 06.03.2026. Verfasst von Anna Maria Bednarek und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Upper Silesian Heart Center, 40-635 Katowice, Poland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia, Medical University of Silesia in Katowice.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Osteoprotegerin (OPG) is recognized as an emerging biomarker for atherosclerosis. We hypothesized that atherosclerotic lesions localized across multiple vascular beds would result in greater elevations in OPG levels in the blood. Therefore, our study aimed to assess serum OPG levels and their confounding factors in patients with hemodynamically significant multivessel atherosclerosis in varying locations. Subjects and Methods: A case–control study included 222 selected outpatients aged 50 years or older (46.4% women) with atherosclerosis confirmed by imaging (Doppler ultrasound and CT angiography) treated at a single angiology clinic. Data concerning age, smoking status, comorbidity (hypertension, diabetes mellitus, history of stroke, myocardial infarction, coronary revascularization procedures), medication, lipid profile, serum creatinine, and homocysteine levels were retrieved from medical records. Additionally, serum OPG levels were measured. Patients were divided according to serum OPG levels into terciles and the number of involved vascular beds [carotid artery disease, coronary heart disease (CHD), lower-extremity peripheral artery disease (PAD), abdominal aorta aneurysm (AAA)].

Results

The distribution of carotid artery disease, CHD, PAD, and AAA did not differ across the OPG terciles. Additionally, we did not observe differences in OPG levels between specific and multiple locations of atherosclerotic lesions. Subjects with the highest OPG levels were the oldest (75.0 ± 8.4 vs. 69.8 ± 7.1 years in the lowest tercile; p < 0.001) and were characterized by the worst kidney function (eGFR 60.8 ± 16.8 vs. 74.1 ± 13.5 mL/min/1.73 m2; p < 0.001).

Conclusions

The serum OPG level did not reveal the specific location of atherosclerosis. Impaired renal function appears to be the primary determinant of serum OPG levels and a key confounder, complicating the interpretation of serum OPG as a biomarker of atherosclerosis.

Schlagwörter

Stichwörter der Autor:innen

abdominal aorta aneurysmatherosclerosisosteoprotegerin

Autor:innen und Institutionen

  • Department of Cardiac Surgery, Upper Silesian Heart Center, 40-635 Katowice, Poland.
  • Health Promotion and Obesity Management Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-751 Katowice, Poland.
  • First Department of Cardiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-635 Katowice, Poland.
  • Department of Internal Medicine and Oncological Chemotherapy, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, 40-029 Katowice, Poland.
  • Angiology Outpatient Clinic "Combi-Med", 42-218 Czestochowa, Poland.

ORCID-Profile: Anna Maria Bednarek, Aleksander Jerzy Owczarek, Dominika Dziadosz, Magdalena Olszanecka-Glinianowicz, Jerzy Tadeusz Chudek

Förderung

  • Medical University of Silesia
  • Medical University of Silesia in Katowice

Zitieren

APA

Bednarek, A. M., Owczarek, A. J., Dziadosz, D., Olszanecka-Glinianowicz, M., & Chudek, J. T. (2026). Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics, 16(5), 786. https://doi.org/10.3390/diagnostics16050786

Vancouver

Bednarek AM, Owczarek AJ, Dziadosz D, Olszanecka-Glinianowicz M, Chudek JT. Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function. Diagnostics. 2026;16(5):786. doi:10.3390/diagnostics16050786

BibTeX
@article{Bednarek2026,
  author = {Bednarek, Anna Maria and Owczarek, Aleksander Jerzy and Dziadosz, Dominika and Olszanecka-Glinianowicz, Magdalena and Chudek, Jerzy Tadeusz},
  title = {Serum Osteoprotegerin Level Is Not a Localizing Biomarker of Atherosclerosis Affected by Kidney Function},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {786},
  doi = {10.3390/diagnostics16050786}
}
Kostenlos starten →